Arulkanthan A, Brown W C, McGuire T C, Knowles D P
Program in Vector-Borne Diseases, Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman, Washington 99164, USA.
Infect Immun. 1999 Jul;67(7):3481-7. doi: 10.1128/IAI.67.7.3481-3487.1999.
Immunization with the native major surface protein 1 (MSP1) (a heterodimer containing disulfide and noncovalently bonded polypeptides designated MSP1a and MSP1b) of the erythrocytic stage of Anaplasma marginale conferred protection against homologous challenge (G. H. Palmer, A. F. Barbet, W. C. Davis, and T. C. McGuire, Science 231:1299-1302, 1986). The MSP1a polypeptide possesses a conserved neutralization-sensitive epitope. In the present study, the immune response to DNA-mediated immunization using msp1a was studied. The plasmid pVCL/MSP1a, which encodes the complete msp1a gene of A. marginale under the control of human cytomegalovirus immediate-early enhancer/promoter and intron A, was constructed. The immune responses elicited by immunization with pVCL/MSP1a into cardiotoxin-induced regenerating muscle were evaluated in mice and cattle. Antibody reactive with native MSP1a was detected in pooled sera of immunized BALB/c mice 3 weeks following primary immunization. Two calves seronegative for A. marginale were immunized four times, at weeks 0, 3, 7, and 13, with pVCL/MSP1a. By 8 weeks, both calves responded to MSP1a with an antibody titer of 1:100, which peaked at 1:1,600 and 1:800 by 16 weeks after the initial immunization. Interestingly, immunoblotting with anti-immunoglobulin G1 (anti-IgG1) and anti-IgG2 specific monoclonal antibodies revealed a restricted IgG1 anti-MSP1a response in both animals. T-lymphocyte lines, established after the fourth immunization, proliferated specifically against A. marginale homogenate and purified MSP1 in a dose-dependent manner. These data provide a basis for an immunization strategy to direct bovine immune responses by using DNA vaccine vectors containing single or multiple genes encoding major surface proteins of A. marginale.
用边缘无浆体红细胞阶段的天然主要表面蛋白1(MSP1)(一种异二聚体,包含通过二硫键和非共价键结合的多肽,分别命名为MSP1a和MSP1b)进行免疫接种可提供针对同源攻击的保护作用(G. H. 帕尔默、A. F. 巴贝特、W. C. 戴维斯和T. C. 麦圭尔,《科学》231:1299 - 1302,1986年)。MSP1a多肽拥有一个保守的中和敏感表位。在本研究中,对使用msp1a进行DNA介导免疫接种的免疫反应进行了研究。构建了质粒pVCL/MSP1a,其在人巨细胞病毒立即早期增强子/启动子和内含子A的控制下编码边缘无浆体的完整msp1a基因。评估了用pVCL/MSP1a接种到心脏毒素诱导的再生肌肉中对小鼠和牛引发的免疫反应。在初次免疫后3周,在免疫的BALB/c小鼠的混合血清中检测到与天然MSP1a反应的抗体。两头边缘无浆体血清学阴性的小牛在第0、3、7和13周用pVCL/MSP1a免疫四次。到8周时,两头小牛对MSP1a的抗体滴度均为1:100,在初次免疫后16周时分别达到峰值1:1600和1:800。有趣的是,用抗免疫球蛋白G1(抗IgG1)和抗IgG2特异性单克隆抗体进行免疫印迹显示,两只动物中均出现有限的IgG1抗MSP1a反应。在第四次免疫后建立的T淋巴细胞系以剂量依赖方式针对边缘无浆体匀浆和纯化的MSP1特异性增殖。这些数据为通过使用包含编码边缘无浆体主要表面蛋白的单个或多个基因的DNA疫苗载体来指导牛免疫反应的免疫策略提供了基础。